. Author manuscript; available in PMC: 2013 May 1.

Published in final edited form as: Nutr Cancer. 2012 Mar 27;64(4):580–587. doi: 10.1080/01635581.2012.661514

Table 2.

Cell cycle distribution and apoptosis of LNCaP cells under different treatments

Treatment (µmol/L)	Cell cycle distribution (%)			Apoptosis (%)
Treatment (µmol/L)	G₁/G₀	S	G₂/M	Apoptosis (%)
Control (NT)	75.7 ± 0.8^a	15.6 ± 0.4^a	8.7 ± 0.3^a	3.2 ± 0.1^a
EGCG 40	65.0 ± 0.7^b	18.8 ± 0.1^b	16.2 ± 0.6^b	8.3 ± 0.2^b
Quer 5	68.4 ± 0.5^c	17.1 ± 0.7^c	14.5 ± 0.5^c	6.6 ± 0.1^c
Quer 10	60.5 ± 0.3^d	20.0 ± 0.2^b	19.5 ± 0.5^d	7.5 ± 0.1^d
EGCG 40 + Quer 5	52.4 ± 0.4^e	20.9 ± 0.6^b	26.7 ± 0.4^e	12.1 ± 0.3^e
EGCG 40 + Quer 10	42.8 ± 0.3^f	23.5 ± 0.7^d	33.7 ± 0.7^f	17.6 ± 0.1^f

LNCaP cells were treated with the indicated concentrations of EGCG and quercetin alone or in combination. Cell cycle distribution and cell apoptosis were detected at 48h post treatment by flow cytometry. Data are presented as mean ± SD. Groups with different superscript letters in each column represent significant difference between groups (P<0.05).